Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $1.39 Million - $2.02 Million
-30,000 Reduced 30.0%
70,000 $3.9 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $4.92 Million - $6.42 Million
100,000 New
100,000 $6.42 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Leonard Green & Partners, L.P. Portfolio

Follow Leonard Green & Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leonard Green & Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Leonard Green & Partners, L.P. with notifications on news.